Business Context and Reporting Period
This Form 8-K is a current report filed by The Gabelli Healthcare & Wellness Rx Trust (GRX) on May 7, 2026. The filing addresses significant personnel changes and health events affecting the Fund's adviser, Gabelli Funds, LLC, and its parent company, GAMCO Investors, Inc.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and personnel matters rather than financial performance.
Material Changes
- Medical Incident: Mario J. Gabelli, Trustee, Chairman, and Chief Investment Officer (CIO), was hospitalized on March 19, 2026, following a medical incident. His condition is improving, but the timeline for his return is unknown.
- Succession Plan Activation: On March 22, 2026, GAMCO activated its succession plan. Christopher J. Marangi was named President of GAMCO.
- Operational Leadership: Day-to-day operations are led by co-CEO Douglas R. Jamieson and Christopher J. Marangi.
- Portfolio Management: During Mr. Gabelli's absence, the Fund's portfolio is managed by Co-Chief Investment Officers Kevin V. Dreyer and Christopher J. Marangi.
Guidance, Outlook, and Risks
The filing does not contain financial guidance or outlook. The primary risk disclosed is the uncertainty surrounding the return of Mr. Gabelli, a key executive. Management emphasizes that operations and portfolio management continue under established interim leadership.
Investor Verification Checklist
- Verify the current status and expected return date of Mario J. Gabelli.
- Confirm the specific roles and responsibilities of the interim portfolio management team (Dreyer and Marangi).
- Monitor future filings for any updates on the succession plan or changes in investment strategy.
- Review the Fund's performance relative to peers during the interim leadership period.